ArticleMolecular therapy. Oncology2025

Optimization of the VSV-G backbone for amino terminal fusion with nanobodies allowing its specific retargeting to HER2 receptors.

Isoline Duquénois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.